MOA Key Laboratory of Animal Virology, Center for Veterinary Sciences, Zhejiang University, Hangzhou, Zhejiang Province, China.
Collaborative innovation center and State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang Province, China.
Autophagy. 2022 Dec;18(12):2781-2798. doi: 10.1080/15548627.2022.2047384. Epub 2022 Mar 10.
Ubiquitination is an important reversible post-translational modification. Many viruses hijack the host ubiquitin system to enhance self-replication. In the present study, we found that VP3 protein was ubiquitinated during infection and supported virus replication by ubiquitination. Mass spectrometry and mutation analysis showed that VP3 was ubiquitinated at residues K73, K135, K158, K193, and K219. Virus rescue showed that ubiquitination at sites K73, K193, and K219 on VP3 could enhance the replication abilities of infectious bursal disease virus (IBDV), and that K135 was essential for virus survival. Binding of the zinc finger domain of TRAF6 (TNF receptor associated factor 6) to VP3 mediated K11- and K33-linked ubiquitination of VP3, which promoted its nuclear accumulation to facilitate virus replication. Additionally, VP3 could inhibit TRAF6-mediated NFKB/NF-κB (nuclear factor kappa B) activation and IFNB/IFN-β (interferon beta) production to evade host innate immunity by inducing TRAF6 autophagic degradation in an SQSTM1/p62 (sequestosome 1)-dependent manner. Our findings demonstrated a macroautophagic/autophagic mechanism by which protein VP3 blocked NFKB-mediated IFNB production by targeting TRAF6 during virus infection, and provided a potential drug target for virus infection control. ATG: autophagy related; BafA1: bafilomycin A; CALCOCO2/NDP52: calcium binding and coiled-coil domain 2; Cas9: CRISPR-associated protein 9; CHX: cycloheximide; Co-IP: co-immunoprecipitation; CRISPR: clustered regularly interspaced short palindromic repeats; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GST: glutathione S-transferase; IBDV: infectious bursal disease virus; IF: indirect immunofluorescence; IFNB/IFN-β: interferon beta; mAb: monoclonal antibody; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MOI: multiplicity of infection; MS: mass spectrometry; NFKB/NF-κB: nuclear factor kappa B; NBR1: NBR1 autophagy cargo receptor; OPTN: optineurin; pAb: polyclonal antibody; PRRs: pattern recognition receptors; RNF125: ring finger protein 125; RNF135/Riplet: ring finger protein 135; SQSTM1/p62: sequestosome 1; TAX1BP1: tax1 binding protein1; TCID50: 50% tissue culture infective dose; TRAF3: TNF receptor associated factor 3; TRAF6: TNF receptor associated factor 6; TRIM25: tripartite motif containing 25; Ub: ubiquitin; Wort: wortmannin; WT: wild type.
泛素化是一种重要的可逆转的翻译后修饰。许多病毒劫持宿主泛素系统来增强自我复制。在本研究中,我们发现 VP3 蛋白在感染过程中发生泛素化,并通过泛素化支持病毒复制。质谱分析和突变分析表明,VP3 在 K73、K135、K158、K193 和 K219 残基上发生泛素化。病毒拯救实验表明,VP3 上 K73、K193 和 K219 位点的泛素化能够增强传染性法氏囊病病毒(IBDV)的复制能力,而 K135 对病毒存活是必需的。TRAF6(TNF 受体相关因子 6)锌指结构域与 VP3 的结合介导了 VP3 的 K11 和 K33 连接的泛素化,促进了其核积累,从而促进了病毒复制。此外,VP3 可以通过诱导 TRAF6 自噬降解来抑制 TRAF6 介导的 NFKB/NF-κB(核因子 kappa B)激活和 IFNB/IFN-β(干扰素 beta)产生,从而逃避宿主先天免疫。本研究发现了一种巨自噬/自噬机制,即在病毒感染过程中,蛋白 VP3 通过靶向 TRAF6 来阻断 NFKB 介导的 IFNB 产生,为病毒感染控制提供了一个潜在的药物靶点。ATG:自噬相关;BafA1:巴佛洛霉素 A;CALCOCO2/NDP52:钙结合和卷曲螺旋结构域 2;Cas9:CRISPR 相关蛋白 9;CHX:环己酰亚胺;Co-IP:免疫共沉淀;CRISPR:成簇规律间隔短回文重复序列;GAPDH:甘油醛-3-磷酸脱氢酶;GST:谷胱甘肽 S-转移酶;IBDV:传染性法氏囊病病毒;IF:间接免疫荧光;IFNB/IFN-β:干扰素 beta;mAb:单克隆抗体;MAP1LC3/LC3:微管相关蛋白 1 轻链 3;MOI:感染复数;MS:质谱;NFKB/NF-κB:核因子 kappa B;NBR1:NBR1 自噬货物受体;OPTN:optineurin;pAb:多克隆抗体;PRRs:模式识别受体;RNF125:环指蛋白 125;RNF135/Riplet:环指蛋白 135;SQSTM1/p62:自噬体相关蛋白 1;TAX1BP1:tax1 结合蛋白 1;TCID50:半数组织培养感染剂量;TRAF3:TNF 受体相关因子 3;TRAF6:TNF 受体相关因子 6;TRIM25:包含三个结构域的 25 号蛋白;Ub:泛素;Wort:wortmannin;WT:野生型。